You just read:

Italian Medicines Agency (AIFA) approves the reimbursement of Zebinix® (eslicarbazepine acetate) as a once daily adjunctive treatment of partial onset seizures in adults

News provided by

Eisai Europe Limited

16 May, 2014, 16:37 BST